+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription

  • PDF Icon


  • 63 Pages
  • June 2023
  • Region: Global
  • GlobalData
  • ID: 5851592
Pharma and healthcare sectors are getting a tech makeover with generative AI. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, this technology is making waves. the publisher latest Innovation Radar report "New prescription: generative AI meets healthcare" unveils the transformative potential of the technology backed by real-world innovations, spanning drug discovery, diagnostics, and clinical documentation. Data privacy and human oversight remain hurdles, but they're not stopping this tech revolution.

Innovations: presents real-world innovation examples related to the generative AI use cases in the pharma and healthcare sectors. It casts light on how pharma sector players are utilizing generative AI technology across key sector-specific application areas.


  • Innovation Insights: innovation examples by generative AI use cases in the pharma and healthcare sector to present key trends.

Reasons to Buy

  • No surprise that technology has been a driving force in business transformation for years, but the term ‘emerging technologies’ has all of a sudden become the key catalyst to drive the next wave of innovation across sectors.
  • The sense of urgency weighs differently across different sectors, where the direct customer-facing sectors are at the forefront compared to other capital-intensive sectors. Companies in one sector can take cues from successful innovations in other sectors to either draw analogies with existing products, services, and processes or transfer strategic approaches for a revolutionary transformation.
  • Against this backdrop, enterprises need to understand which emerging technologies are impacting their sector and how various companies are implementing them to meet various challenges.
  • The innovation landscape report on pharma and healthcare innovations in generative AI, released by the publisher as part of an ongoing series, covers some real-world examples to advance the development and implementation of the technology by some of the key enterprises in the pharma and healthcare sector.

Table of Contents

1. Sector exposure map in genAI

2. Impact on the pharma value chain

3. Thought leadership

4. Major application areas

5. Key use cases

6. Real-world innovations

7. Outlook

8. Appendix

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M HIS
  • Absci
  • Adaptyv Bio
  • Carbon Health
  • Chinese Academy of Sciences
  • Clarify Health
  • DiagnaMed
  • Elevance Health
  • Eli Lilly
  • Epic Systems
  • Glass Health
  • Google
  • Harvard Medical School
  • Hebei University
  • Huma.AI
  • IKS Health
  • Illumina
  • Insilico Medicine
  • Lumeris
  • Massive Bio
  • Microsoft
  • Novartis
  • NYU Grossman School of Medicine
  • PathAI
  • Pieces Technologies
  • Quralis
  • Segmed
  • SimConverse
  • Skyscape
  • Solutionreach
  • Sygnature Discovery
  • Syntegra
  • Tempus
  • UNC Health
  • WELL Health
  • Wellspan Health